Effects of 2 mg Chlormadinone Acetate/0.03 mg Ethinylestradiol in Primary Dysmenorrhoea: The BEDY (Belara(R) Evaluation on Dysmenorrhea) Study - an Open, Non-Comparative, Non-Interventional Observational Study with 4,842 Women

Schramm GAK; Waldmann-Rex S

Schramm GAK, Waldmann-Rex S

Effects of 2 mg Chlormadinone Acetate/0.03 mg Ethinylestradiol in Primary Dysmenorrhoea: The BEDY (Belara(R) Evaluation on Dysmenorrhea) Study - an Open, Non-Comparative, Non-Interventional Observational Study with 4,842 Women

Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (Sonderheft 1): 112-118

Volltext (PDF) Summary Abbildungen

Abbildung

Vollbildansicht	BEDY-Study - Age distribution Abbildung 1: Age distribution of women in the efficacy sample (n = 4514). Keywords: Kontrazeption


Vollbildansicht	BEDY Study - Dysmenorrhoea Abbildung 2: Intensity of dysmenorrhoea symptoms before and after the administration of 2 mg chlormadinone acetate/ 0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown (n = 3857). Keywords: Kontrazeption


Vollbildansicht	BEDY Study - Analgesic Treatment Abbildung 3: Incidence and frequency of analgesic treatment due to dysmenorrhoea, before and after the administration of 2 mg chlormadinone acetate/0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown (n = 3860). Keywords: Kontrazeption


Vollbildansicht	BEDY Study - Dysmenorrhoea Abbildung 4: Absence from school or work due to dysmenorrhoea, before and after the administration of 2 mg chlormadinone acetate/0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown (n = 3722). Keywords: Kontrazeption


Vollbildansicht	BEDY Study - Skin and Hair Symptoms Abbildung 5: Incidence and intensity of skin and hair symptoms, before and after the administration of 2 mg chlormadinone acetate/0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown (n = 3951, Acne Prone Skin; n = 3934, Greasy Hair). Keywords: Kontrazeption


Vollbildansicht	BEDY Study - Cycle-Related Disorders Abbildung 6: Incidence of moderate to severe symptoms in other cycle-related disorders, before and after the administration of 2 mg chlormadinone acetate/0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown. Keywords: Kontrazeption